Neonc Technologies Holdings (NTHI) EBIT (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly EBIT of -$7.1 million for Q1 2026, up 77.88% year-over-year from -$4.0 million in Q1 2025, and up 48.49% quarter-over-quarter from -$13.7 million in Q4 2025.
Neonc Technologies Holdings (NTHI) EBIT (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported EBIT for 3 consecutive years, with -$7.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT rose 77.88% year-over-year to -$7.1 million; the TTM figure through Mar 2026 stood at -$33.4 million (up 10.93% YoY), while the FY2025 annual figure was -$58.2 million, down 715.4% from the prior year.
- EBIT climbed to -$7.1 million in Q1 2026 per NTHI's latest filing, from -$13.7 million in the prior quarter.
- Across five years, EBIT topped out at -$1.3 million in Q2 2024 and bottomed at -$31.9 million in Q1 2025.
- Historically, EBIT has averaged -$8.0 million across 3 years, with a median of -$5.7 million in 2025.
- Annual changes were most pronounced in 2025 — EBIT sank 1956.15% — and 2026, when it jumped 77.88%.
- Neonc Technologies Holdings' EBIT stood at -$2.1 million in 2024, then plunged by 548.0% to -$13.7 million in 2025, then surged by 48.49% to -$7.1 million in 2026.
- Business Quant data shows NTHI's EBIT at -$7.1 million in Q1 2026, -$13.7 million in Q4 2025, and -$6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -14.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.07 Mn |
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -13.70 Mn |
| Sep 30, 2025 | -6.93 Mn |
| Jun 30, 2025 | -5.71 Mn |
| Mar 31, 2025 | -31.90 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Sep 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.55 Mn |